← Leaderboards
Murali-Krishna Kaja
University Of Washington
$5,864,916
Attributed
$6,443,074
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $707K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,443,074 · 6
By mechanism
R01$4,196,729 · 3
U19$1,537,801 · 1
R21$480,000 · 1
P51$228,544 · 1
Top collaborators
- Mehul Shamal Suthar3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Timothy M Rose$18,057,130
- Judith N. Wasserheit$2,842,926
- Wesley C Van Voorhis$32,631,211
- Joshua Woodward$10,445,693
- Mehul Shamal Suthar$8,747,894
Others in their field
Top investigators on “Immunity”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmunityImmune ResponseCellsVaccinesResponseInfectionT-LymphocyteIn VivoViralAntigensVirusVaccination StrategyGenerationsSignal TransductionClonal ExpansionResearch StudyMemoryImmune SystemInterferonsPathogenVaccinationImmuneInsightAffect
Grant awards (20)
Immune responses associated with severe disease in patients with primary dengue infection$521,185
R01 · FY2025 · AI · contact PI
Immune responses associated with severe disease in patients with primary dengue infection$29,279
R01 · FY2025 · AI · contact PI
Immune responses associated with severe disease in patients with primary dengue infection$605,852
R01 · FY2024 · AI · contact PI
IFN actions and immune cell activation by West Nile Virus$281,789
U19 · FY2013 · AI · contact PI
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I$383,625
R01 · FY2012 · AI · contact PI
IFN actions and immune cell activation by West Nile Virus$318,626
U19 · FY2012 · AI · contact PI
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I$383,625
R01 · FY2011 · AI · contact PI
IFN actions and immune cell activation by West Nile Virus$311,697
U19 · FY2011 · AI · contact PI
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I$390,000
R01 · FY2010 · AI · contact PI
IFN actions and immune cell activation by West Nile Virus$308,674
U19 · FY2010 · AI · contact PI
Novel Vaccination Strategies Against Epidemic and Pandemic Influenza Viruses to I$390,000
R01 · FY2009 · AI · contact PI
IFN actions and immune cell activation by West Nile Virus$317,015
U19 · FY2009 · AI · contact PI
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE$287,488
R01 · FY2007 · AI · contact PI
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE$296,075
R01 · FY2006 · AI · contact PI
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE$303,200
R01 · FY2005 · AI
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE$303,200
R01 · FY2004 · AI
CD8 T-CELL RESPONSE$228,544
P51 · FY2004 · RR
ROLE OF TYPE-I IFN'S IN ANTIVIRAL CD8 CELL RESPONSE$303,200
R01 · FY2003 · AI
Potentiation Immune Resp vs HIV vacc Modula Innate Resp$240,000
R21 · FY2002 · AI
Potentiation Immune Resp vs HIV vacc Modula Innate Resp$240,000
R21 · FY2001 · AI